4-Chlorobenzenesulfonyl Chloride
| Purity | Grade | Package | Stock | Price | Quantity |
|---|---|---|---|---|---|
| 98% | RG | 25G | In Stock | 2 USD | |
| 98% | RG | 100G | In Stock | 6 USD | |
|
Should you have any questions, please contact us by Email. |
|||||
Applications of 98-60-2
4-Chlorobenzenesulfonyl chloride is widely used in:
- Organic Synthesis: As a reagent for synthesizing sulfonamides and other organic compounds.
- Pharmaceuticals: In the preparation of active pharmaceutical ingredients, particularly those targeting cancer and bacterial infections.
- Chemical Intermediates: In the production of dyes and agrochemicals.
Biological Activity of 98-60-2
The biological activity of 4-chlorobenzenesulfonyl chloride is significant in medicinal chemistry. It serves as an intermediate in the synthesis of various pharmaceuticals, including anti-cancer agents and antibiotics. Its derivatives have shown moderate cytotoxicity against several cancer cell lines, highlighting its potential therapeutic applications.
NMR spectrum of 98-60-2
Safety Information of 98-60-2
Download COA of 98-60-2
Bulk Packaging Price Explanation of 98-60-2
Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.
Purchase Instructions of 98-60-2
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.

